A drug delivery system is a device created for the input of a therapeutic component into the body. The electronic drug delivery system is an advanced drug delivery system which is designed by implementation of technological advancements and innovations according to the requirement and comfort level of patients. In this era, different technologies are being merged with computation tools to provide innovations in drug delivery systems such as electronic drug delivery system. It offers several benefits to patients, which includes caregivers, medical professionals, and drug regimens. Electronic drug delivery systems help in delivering the drug to specific parts of the body.

To have an edge over the competition by knowing the market dynamics and current trends of “Electronic Drug Delivery Systems Market”, request for Sample Report here

The factors driving the growth of the global electronic drug delivery systems market include the ease of self-administration for patients, lesser load on hospitals & clinics, and increasing prevalence of diseases such as asthma, diabetes and cardiovascular diseases. The continuous technological advancements due to the shift towards the vision of industry 4.0 is bringing innovations in drug delivery systems worldwide. There are numerous patients with diseases like tuberculosis and diabetes and they are advised to adhere to the prescription, which can be easy followed by the electronic drug delivery system. EDDS ensures whether the medications are delivered properly to the patient’s body or not. It helps in reminding the patients about their drugs intake routine and provides appropriate guidance on how to use their medications. These features are propelling the growth of the global electronic drug delivery systems market.

Moreover, scientists and researchers are conducting studies on major problems faced by patients while delivering drugs in their bodies to enhance the technologies in electronic drug delivery systems. There are several benefits of electronic drug delivery systems as compared to traditional drug delivery methods, such as enhanced efficiency, lesser time consumption, minimum side effects, and self-administered therapy for patients. These features and increasing innovations to offer improved solutions are certain factors that are playing a significant role in driving the growth of the global electronic drug delivery systems market.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Based on the type, the market is segmented into electronic wearable infusion pumps, electronic autoinjectors, electronic injection pumps, and electronic inhalers. The electronic wearable infusion pumps segment is projected to grow at a higher CAGR during the forecast period attributed to the massive availability of these electronic drug systems as compared to other types of electronic drug delivery systems. Electronic wearable infusion pumps are broadly used to manage diabetes. The increasing volume of patients suffering from this disease is another factor that is surging the growth of the segment.

Based on the indication, the market is segmented into diabetes, multiple sclerosis, cardiovascular disease, asthma & COPD, and other indications. The diabetes segment is anticipated to witness a faster CAGR over the forecast period attributed to the enormous availability of diabetes patients across the globe. Also, there is a substantial availability of electronic drug delivery systems for this disease, such as injection pens and insulin pumps. This factor is energizing the growth of the diabetes segment in the global electronic drug delivery systems market.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Based on the region, the North America region is expected to grow at a higher CAGR over the forecast period. In this region, there is a significant prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and asthma. The researchers are working to bring innovation in electronic drug delivery systems in order to improve the solutions for the targeted diseases. These innovations are increasing the demand for electronic drug delivery systems to get a better cure option with fewer visits to the hospital. This increase in demand is anticipated to surge the growth of the electronic drug delivery systems market in North America region.

Various notable players operating in the market include Merck KGaA, Insulet Corporation, Bayer AG, Medtronic, United Therapeutics Corporation, Companion Medical, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Amgen Inc., and AstraZeneca, among others. 

Key Developments: 

• • In 2020, Medtronic launched a new cloud-based data management software, named Efficio, developed for use with the SynchroMed II intrathecal drug delivery system. It will enable clinicians to manage delivery pump practices more efficiently to treat patients with severe spasticity, cancer pain, and chronic pain.
  • In 2019, AstraZeneca collaborated with Aptamer Group, one of the biotechnology company, to develop drug delivery devices targeting the kidney. This collaboration helped AstraZeneca to explore the usage of aptamer technology.

The global Electronic Drug Delivery Systems market has been segmented on the basis of type, indication, and key regions. Based on type, the market is segmented into electronic wearable infusion pumps, electronic autoinjectors, electronic injection pumps, and electronic inhalers. Based on indication, the market is segmented into diabetes, multiple sclerosis, cardiovascular disease, asthma & COPD, and other indications. 

For detailed scope of the “Electronic Drug Delivery Systems Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global electronic drug delivery systems market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in electronic drug delivery systems market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global electronic drug delivery systems market?
  • Which type generated maximum revenues in 2019 and identify the most promising type during the forecast period?
  • What are the various indication areas of global electronic drug delivery systems market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Report Coverage	Details
Market Base Year	2019
Market Forecast Period	2020-2027
Market Revenues Currency	USD Million
Base Year & Forecast Units	Revenues (USD Million)
Market Segment	By Type, By Indication, By Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	Merck KGaA, Insulet Corporation, Bayer AG, Medtronic, United Therapeutics Corporation, Companion Medical, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Amgen Inc., AstraZeneca, among others; a total of 10 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Global Electronic Drug Delivery Systems Market by Type

• • Electronic Wearable Infusion Pumps
  • Electronic Autoinjectors
  • Electronic Injection Pens
  • Electronic Inhalers

Global Electronic Drug Delivery Systems Market by Indication

• • Diabetes
  • Multiple Sclerosis
  • Cardiovascular Disease
  • Asthma & COPD
  • Other Indications

Global Electronic Drug Delivery Systems Market by Region

• • North America Electronic Drug Delivery Systems Market (Option 1: As a part of the free 25% customization)
    • North America Electronic Drug Delivery Systems Market by Type
    • North America Electronic Drug Delivery Systems Market by Indication
    • US Electronic Drug Delivery Systems Market All-Up
    • Canada Electronic Drug Delivery Systems Market All-Up
  • Europe Electronic Drug Delivery Systems Market (Option 2: As a part of the free 25% customization)
    • Europe Electronic Drug Delivery Systems Market by Type
    • Europe Electronic Drug Delivery Systems Market by Indication
    • UK Electronic Drug Delivery Systesms Market All-Up
    • Germany Electronic Drug Delivery Systems Market All-Up
    • France Electronic Drug Delivery Systems Market All-Up
    • Spain Electronic Drug Delivery Systems Market All-Up
    • Rest of Europe Electronic Drug Delivery Systems Market All-Up
  • Asia-Pacific Electronic Drug Delivery Systems Market (Option 3: As a part of the free 25% customization)
    • Asia-Pacific Electronic Drug Delivery Systems Market by Type
    • Asia-Pacific Electronic Drug Delivery Systems Market by Indication
    • China Electronic Drug Delivery Systems Market All-Up
    • India Electronic Drug Delivery Systems Market All-Up
    • Japan Electronic Drug Delivery Systems Market All-Up
    • Rest of APAC Electronic Drug Delivery Systems Market All-Up
  • RoW Electronic Drug Delivery Systems Market (Option 4: As a part of the free 25% customization)
    • RoW Electronic Drug Delivery Systems Market by Type
    • RoW Electronic Drug Delivery Systems Market by Indication
    • Brazil Electronic Drug Delivery Systems Market All-Up
    • South Africa Electronic Drug Delivery Systems Market All-Up
    • Saudi Arabia Electronic Drug Delivery Systems Market All-Up
    • UAE Electronic Drug Delivery Systems Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Electronic Drug Delivery Systems Market All-Up

Major Players Operating in the Electronic Drug Delivery Systems (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Merck KGaA
  • Insulet Corporation
  • Bayer AG
  • Medtronic
  • United Therapeutics Corporation
  • Companion Medical
  • Novo Nordisk A/S
  • Hoffmann-La Roche Ltd
  • Amgen Inc.
  • AstraZeneca